Tachycardia, Supraventricular
14
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
Cardiac Arrhythmias at Extreme Altitude
Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias
The IPED (Investigation of Palpitations in the ED) Study
TOCCATA - Touch+™ for Catheter Ablation
cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
Epidemiology of Symptomatic Arrhythmias
Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping